Advertisement
Screener

Stock Idea: Buy Ratings, Foreign Stocks

Buy analyst ratings: Foreign

2,752 dated buy ratings on 290 Foreign stocks (depositary receipts, New York registry shares and stocks traded over the counter), newest first. The firms' own words in this tab: Buy, Outperform, Overweight. Each row is as the research firm published it in its public rating disclosure. Not investment advice and not a consensus.

  • 2026-09-11: Stock LEGN; Price Target $74.00; Price When Rated $19.91; Upside / Downside +271.67%.
  • 2026-09-10: Stock BYDDF; Price Target $20.00; Price When Rated $10.73; Upside / Downside +86.39%.
  • 2026-09-09: Stock BEIGF; Price Target $415.00; Price When Rated $351.48; Upside / Downside +18.07%.
  • 2026-09-09: Stock ONC; Price Target $415.00; Price When Rated $351.48; Upside / Downside +18.07%.
DateStockPrice TargetPrice When RatedUpside / DownsideAnalystFirmRating
2026-09-11LEGN
Legend Biotech Corp
$74.00$19.91+271.67%Etzer DaroutBarclaysOverweight
2026-09-10BYDDF
BYD CO LTD
$20.00$10.73+86.39%Jiong ShaoBarclaysOverweight
2026-09-09BEIGF
BeOne Medicines Ltd.
$415.00$351.48+18.07%Etzer DaroutBarclaysOverweight
2026-09-09ONC
BeOne Medicines Ltd.
$415.00$351.48+18.07%Etzer DaroutBarclaysOverweight
2026-09-08TMSOF
THOMSON REUTERS CORP /CAN/
$130.00$105.68+23.01%Manav PatnaikBarclaysOverweight